These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38605963)

  • 1. Probiotic lactic acid bacteria promote anti-tumor immunity through enhanced major histocompatibility complex class I-restricted antigen presentation machinery in dendritic cells.
    Saito S; Okuno A; Peng Z; Cao DY; Tsuji NM
    Front Immunol; 2024; 15():1335975. PubMed ID: 38605963
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Saito S; Kakizaki N; Okuno A; Maekawa T; Tsuji NM
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33121026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.
    Herrera OB; Brett S; Lechler RI
    Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
    Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
    J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class I-mediated exogenous antigen presentation by exosomes secreted from immature and mature bone marrow derived dendritic cells.
    Utsugi-Kobukai S; Fujimaki H; Hotta C; Nakazawa M; Minami M
    Immunol Lett; 2003 Oct; 89(2-3):125-31. PubMed ID: 14556969
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Saito S; Okuno A; Kakizaki N; Maekawa T; Tsuji NM
    Biosci Microbiota Food Health; 2022; 41(3):130-136. PubMed ID: 35854694
    [No Abstract]   [Full Text] [Related]  

  • 7. Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells.
    Adams EW; Ratner DM; Seeberger PH; Hacohen N
    Chembiochem; 2008 Jan; 9(2):294-303. PubMed ID: 18186095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
    Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
    Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized mobilization of MHC class I- and II- restricted immunity by dendritic cell vaccine potentiates cancer therapy.
    Shi Y; Liu Y; Huang J; Luo Z; Guo X; Jiang M; Li X; Lu Y; Liu X; Shan X; Luo L; You J
    Theranostics; 2022; 12(7):3488-3502. PubMed ID: 35547749
    [No Abstract]   [Full Text] [Related]  

  • 10. Bacterial heat shock proteins promote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8+ T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages.
    Tobian AA; Canaday DH; Boom WH; Harding CV
    J Immunol; 2004 May; 172(9):5277-86. PubMed ID: 15100266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population.
    Wu CC; Liu SJ; Chen HW; Shen KY; Leng CH
    Oncotarget; 2016 May; 7(21):30804-19. PubMed ID: 27127171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells can prime anti-tumor CD8
    MacNabb BW; Tumuluru S; Chen X; Godfrey J; Kasal DN; Yu J; Jongsma MLM; Spaapen RM; Kline DE; Kline J
    Immunity; 2022 Jun; 55(6):982-997.e8. PubMed ID: 35617964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
    Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
    J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
    J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baccatin III, a synthetic precursor of taxol, enhances MHC-restricted antigen presentation in dendritic cells.
    Lee YH; Lee YR; Kim KH; Im SA; Song S; Lee MK; Kim Y; Hong JT; Kim K; Lee CK
    Int Immunopharmacol; 2011 Aug; 11(8):985-91. PubMed ID: 21354357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transduction of dendritic cells by antigen-encoding lentiviral vectors permits antigen processing and MHC class I-dependent presentation.
    Zarei S; Leuba F; Arrighi JF; Hauser C; Piguet V
    J Allergy Clin Immunol; 2002 Jun; 109(6):988-94. PubMed ID: 12063529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relative efficiency of acquisition of MHC:peptide complexes and cross-presentation depends on dendritic cell type.
    Smyth LA; Harker N; Turnbull W; El-Doueik H; Klavinskis L; Kioussis D; Lombardi G; Lechler R
    J Immunol; 2008 Sep; 181(5):3212-20. PubMed ID: 18713992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-independent mechanism of major histocompatibility complex class I loading.
    Robson NC; Beacock-Sharp H; Donachie AM; Mowat AM
    Immunology; 2003 Jul; 109(3):374-83. PubMed ID: 12807483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesicular Stomatitis Virus Encoding a Destabilized Tumor Antigen Improves Activation of Anti-tumor T Cell Responses.
    Huff AL; Evgin L; Thompson J; Kottke T; Driscoll CB; Tonne J; Wongthida P; Schuelke M; Shim KG; Mer G; Ramirez-Alvarado M; Vile R
    Mol Ther; 2020 Dec; 28(12):2540-2552. PubMed ID: 32877695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.